UCB — Board/Management Information 2014

Mar 25, 2014

Jean-Christophe Tellier

Jean-Christophe Tellier joined UCB in 2011. He has become CEO-Elect since March 1, 2014 after having successfully led UCB's BioBrands and Solutions division as Executive Vice President.

Jean-Christophe Tellier is an experienced global leader. He was trained as a Medical Doctor and specialized in rheumatology. He has built a distinguished 25-year career in the biopharmaceutical industry, taking on different global leadership responsibilities in different parts of the world.

His patient-centric approach, his passion for science, combined with his strategic and operational skills, have allowed him to significantly contribute to UCB's success in recent years. He was the main architect of the new Patient Solutions organization UCB implemented a year ago.

For Jean-Christophe "engaging the patient in our vision is the best way for our company to be successful in the long term. Having a holistic view of a patient, of his/her life in his/her environment is essential to ensure effective treatment". Jean-Christophe also believes that "all healthcare players - physicians, payors, carers, industry and academia - should cooperate even more effectively and become stronger partners sharing a same goal: improving patient care".

As a leader, Jean-Christophe has always had a passion for developing people, which he sees as "a key force to drive company success". His ambition is to continue to further engage UCB teams behind the company's vision and fully leverage UCB's strong culture and talents.

Key positions

Prior to UCB, Jean-Christophe held the following positions:

2009	Ipsen: President and General Manager of Ipsen's North American operations
	Managed Ipsen's specialty care business in endocrinology and neurology in the US
2008	Macrogenics: Maryland-based private biotechnology company Executive Vice President and Chief Commercial Officer
	In charge of developing and commercializing innovative drugs to treat auto-immune disorders, cancers, and infectious diseases
1989 – 2008	Novartis: CEO of Novartis Pharma France
	CEO of Novartis Pharma Belgium – was President of the Board of the Belgian Pharma Trade association (pharma.be)
	Built his career in several local and global marketing and sales positions; was a.o. Head of Novartis' Global Business Franchise in Arthritis, Bone and Muscle Disease

Education

Doctor of Medicine (M.D.) – University of Reims Champagne-Ardenne, France Post-graduate: Rheumatologist - University of Paris V, France Executive business programs at Harvard and INSEAD

Update: March 2014